Related Experiment Video
Updated: Jun 8, 2025
08:10
Robotic Lateral Pancreaticojejunostomy for Chronic Pancreatitis
Published on: December 14, 2019
11.0K
Preventive Measures and Risk Factors for Post-ERCP Pancreatitis: A Systematic Review and Individual Patient Data
Christina J Sperna Weiland1, Venkata S Akshintala2, Anmol Singh2
1Department of Gastroenterology and Hepatology, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GM, Nijmegen, Netherlands. Christa.spernaweiland@radboudumc.nl.
Digestive Diseases and Sciences
|November 5, 2024
Summary
Rectal NSAIDs and high-volume IV fluids effectively reduce post-ERCP pancreatitis (PEP). Pancreatic duct stents showed no benefit, while difficult cannulation and prior PEP history increase risk. Personalized prophylaxis strategies are needed.
Area of Science:
- Gastroenterology
- Clinical Trials
- Medical Interventions
Background:
- Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) is a significant clinical challenge.
- Limited data exist on combined prophylactic measures and their efficacy based on patient risk profiles.
Approach:
- Conducted an individual patient data meta-analysis (IPDMA) of randomized controlled trials on PEP prophylaxis.
- Systematically searched major databases and invited authors to share individual patient data.
- Utilized multilevel logistic regression to analyze PEP incidence and compare prophylaxis efficacy.
Key Points:
- Rectal NSAIDs and peri-procedural high-volume IV fluids significantly reduced PEP incidence.
- Pancreatic duct stents did not demonstrate a significant benefit in PEP prevention.
- Difficult cannulation, pancreatic duct contrast injection, and prior PEP history increased PEP risk.
Conclusions:
- Rectal NSAIDs and peri-procedural IV fluids are effective PEP prophylactic strategies.
- Further research into combination therapies and personalized risk calculators is warranted to optimize PEP prevention.
Related Concept Videos
01:26Endoscopic Procedures V: ERCP
107
Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
Patient...
107
01:29Chronic Pancreatitis II: Collaborative Care
70
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
70
01:24Chronic Pancreatitis I: Introduction
72
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
72
01:30Acute Pancreatitis II: Clinical Manifestations and Management
93
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
93
01:27Acute Pancreatitis I: Introduction
336
Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
336
01:26Peptic Ulcer Disease IV: Management
74
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
74